These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11263457)

  • 1. Evidence and belief in attention deficit hyperactivity disorder. Narrow focus of editorial was disappointing.
    Timimi S
    BMJ; 2001 Mar; 322(7285):555-6. PubMed ID: 11263457
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
    Bonati M; Impicciatore P; Pandolfini C
    BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
    Reitz SJ
    J Pediatr Health Care; 1997; 11(2):78-83. PubMed ID: 9155352
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
    Kollins SH; March JS
    Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

  • 10. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Attention deficit hyperkinetic syndrome (ADHS) and stimulants].
    Rothenberger A
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):159-61. PubMed ID: 12227218
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A; Jørgensen JI
    Ugeskr Laeger; 2004 Jan; 166(3):144-8. PubMed ID: 14870640
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder psychopharmacology for college students.
    Staufer WB; Greydanus DE
    Pediatr Clin North Am; 2005 Feb; 52(1):71-84, viii. PubMed ID: 15748925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.